Ipsum Diagnostics Now Offering Testing for Monkeypox Virus
July 25, 2022
The MPX IDx assay is now available as monkeypox case counts continue to rise across the U.S. Atlanta, GA – Ipsum Diagnostics LLC is now
* The US Food and Drug Administration on Wednesday, April 1st 2020 granted Emergency Use Authorization (EUA) to Ipsum Diagnostics for the company’s RT-PCR-based SARS-CoV-2 test. The FDA EUA increased our testing capacity processing from 1000 to 10,000 tests per day.
Total Reported: 1,200,000+
Turnaround
0.5 Days
The MPX IDx assay is now available as monkeypox case counts continue to rise across the U.S. Atlanta, GA – Ipsum Diagnostics LLC is now
Ipsum Diagnostics LLC is attending the Executive War Conference in New Orleans this week! Ipsum Diagnostics is a CAP-accredited, independent national reference laboratory providing an
Ipsum Diagnostics honors and celebrates our Medical Laboratory Professionals during lab week April 24th – 30th for their incredible contributions and for all they do.
We are thrilled to announce and share that Leah Roberts has been selected to receive the 2022 Wesleyan Alumnae Association’s Award. She is most deserving
8607 Roberts Drive
Suite 250
Atlanta, GA 30350
Phone: 678-915-2299
Fax: 844-364-8451
info@ipsumdiagnostics.com
Hours: Mon – Fri: 8am – 6pm
CAP No. 857023601 CLIA No. 11D2125186
Copyright © 2021 Ipsum Diagnostics. All Rights Reserved.